IOMAI CORPORATION |
End-of-day quote
Other stock markets
|
||
| - | - |
|
| Managers | Title | Age | Since |
|---|---|---|---|
Reinhard Kandera
BRD | Director/Board Member | 54 | - |
Franck Grimaud
BRD | Director/Board Member | 58 | 15-11-30 |
Robert C. Seid
PRN | Corporate Officer/Principal | - | 08-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
F. Weller Meyer
BRD | Director/Board Member | 81 | 05-12-31 |
David Lawrence
BRD | Director/Board Member | 61 | 17-10-31 |
| Director/Board Member | 85 | 06-07-04 |
Intercell USA, Inc. provides products for the delivery of vaccines to the skin through a proprietary technology known as transcutaneous immunization, or TCI. The Company is evaluating skin immunization techniques in several human clinical trials, including those to prevent influenza in the healthy adult and elderly populations, and also to prevent travelers' diarrhea and anthrax infection.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -3.79% | 86.13B | |
| +1.97% | 39.82B | |
| +56.59% | 25.23B | |
| -14.82% | 15.36B | |
| -8.82% | 11.95B | |
| -16.29% | 11.6B | |
| -41.58% | 11.51B | |
| +6.14% | 8.71B | |
| -7.02% | 8.12B |
- Stock Market
- Equities
- Stock
